This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Wed, 06/19/2024 - 20:57 June 19, 2024 — When electrophysiologist Eugenio Cingolani, MD , isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heart rhythm disorders. Unfortunately, ablation also destroys healthy heart tissue in the process. Eugenio Cingolani, MD.
Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.
She had a single chamber ICD/Pacemaker implanted several years prior due to ventricular tachycardia. Answer : The ECG above shows a regular wide complex tachycardia. Said differently, the ECG shows a rather slow ventricular tachycardia with a 2:1 VA conduction. Cardiac output (CO) was being maintained by the tachycardia.
A patient in the ICU with significant underlying cardiac disease [HFrEF 30%, non-ischemic cardiomyopathy, LBBB s/p CRT-D (biventricular pacer), AVNRT s/p ablation a few yrs ago, hx sinus tachycardia while on max tolerated BB therapy] went into a regular wide-complex tachycardia after intubation for severe COPD exacerbation.
BackgroundCryoablation for pediatric atrioventricular nodal reentry tachycardia (AVNRT) is favored for reducing conduction system injury compared to radiofrequency (RF) ablation. ResultsAmong 95 patients, 69 received RF ablation and 26 received cryoablation. Recurrence rates were 2.9% vs. 11.5%, p>0.99).
My understanding is that the decision was made for today's patient to be formally evaluated by EP cardiology with consideration given to ablation and/or insertion of an ICD ( I mplantable C ardioverter D efibrillator ). I offer the above as retrospective reflection to stimulate discussion on actions to consider.
In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.
This strip was obtained: Apparent Wide Complex Tachycardia at a rate of 280 What do you think? Troponins 34>33>43, likely secondary to myocardial injury from tachycardia. The patient was started on amiodarone, anticoagulation, and metoprolol, and scheduled for atrial flutter ablation. He underwent ablation in the EP Lab.
Image courtesy: Getty Images christine.book Wed, 07/24/2024 - 09:00 July 24, 2024 — Volta Medical , a health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, has announced a Joint Development Agreement with GE HealthCare. The company has obtained U.S.
milla1cf Tue, 03/05/2024 - 12:02 March 5, 2024 — Biosense Webster, Inc. , 2** Furthermore, the primary effectiveness endpoint (PEE) of acute pulmonary vein isolation and 12-month freedom from atrial arrhythmia recurrence (AF, Atrial Tachycardia, or Atrial Flutter) was 75.6%. iii] The study reported a low fluoroscopy time of 7.8
Circulation, Volume 150, Issue Suppl_1 , Page A4148156-A4148156, November 12, 2024. Background:Patients with adult congenital heart disease (ACHD) form a unique subset of patients with complex ventricular tachycardia (VT).Objective:To These patients were younger compared to the non-ACHD subtype.
Circulation, Volume 150, Issue Suppl_1 , Page A4142266-A4142266, November 12, 2024. Introduction:Supraventricular tachycardia (SVT) is common and poorly tolerated in patients who have undergone Fontan procedure. Recurrence rates after catheter ablation in these patients are high. Ablation success rate was 92%.
ABSTRACT Background Low voltage bridge mapping (LVBM) is an approach to atrio-ventricular nodal reentry tachycardia (AVNRT) ablation that has been postulated to facilitate the procedure. In our center, AVNRT ablations were performed with the traditional radio frequency current (RF) current approach using the CARTO mapping system.
This progressed to electrical storm , with incessant PolyMorphic Ventricular Tachycardia ( PMVT ) and recurrent episodes of Ventricular Fibrillation ( VFib ). The patient improved, and on Day-11 of the hospital stay — he was off inotropes and on a small dose of a ß-blocker. He required multiple defibrillations within a period of a few hours.
Figure-1: While at first glance the rhythm in Figure-1 might be mistaken for sinus tachycardia in fact, this is not the rhythm. If the upright deflection in lead V1 was a single sinus P wave then the PR interval would be longer-than-expected for this to be sinus tachycardia. Figure-1: The initial ECG in today's case.
Ventricular tachycardia can be a killer arrhythmia that can arrest the heart within seconds or behave like your pet, gently cuddling the heart and terminating spontaneously. We still need the assistance of drugs in many classes of VT, even after ablation as well as an ICD. 2024 Aug 31:S2405-500X(24)00708-4. doi: 10.1016/j.jacep.2024.08.004.
Late-breaking results from the VANISH2 trial presented at AHA 2024 showed that catheter ablation might be a better first-line treatment than antiarrhythmic drugs for ventricular tachycardia patients with ischemic cardiomyopathy. Over a median of 4.3 Over a median of 4.3
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content